Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 500 results in range #1,501 to #2,000.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. ODIXa-DVTOral Direct Factor Xa Inhibitor Bay 59-7939 In Patients With Acute Symptomatic Deep-Vein Thrombosis
  2. ORBITOral Glycoprotein IIb/IIia Receptor Blockade To Inhibit Thrombosis
  3. OSIRISOral Sirolimus To Inhibit Recurrent In-Stent Stenosis
  4. ORAR IIOral Treatment Of Restenosis
  5. TIMI 16-OPUSOrbofiban In Patients With Unstable Coronary Syndromes, Thrombolysis In Myocardial Infarction
  6. OASIS-6Organization For The Assessment Of Strategies For Ischemic Syndromes 6
  7. OASIS-1Organization To Assess Strategies For Ischemic Syndromes
  8. Oscar MinkowskiOskar Minkowski
  9. Otto WarburgOtto Warburg (botanist)
  10. OPTIME-CHFOutcomes Of A Prospective Trial Of Intravenous Milrinone For Exacerbations Of Chronic Heart Failure
  11. OPT-CHFOxypurinol Compared With Placebo For Class III-Iv Nyha Congestive Heart Failure
  12. User talk:ShivnkorP90x
  13. PCI Complications: Radiocontrast toxicityPCI Complications: Renal Failure#Toxicities Associated with Radiocontrast Agents
  14. Heparin-associated thrombocytopeniaPCI Complications: Thrombocytopenia#Heparin-Associated and Heparin-Induced Thrombocytopenia
  15. PCI in the Patient Requiring CPR and Refractory Ventricular ArrhythmiasPCI in the patient requiring CPR and refractory ventricular arrhythmias
  16. PCI in the Sole Remaining ConduitPCI in the sole remaining conduit
  17. Coronary angiography PERFUSE thrombus grade 4 case studiesPERFUSE thrombus grade 4 case studies
  18. PASEPacemaker Selection In The Elderly
  19. ISAR DIABETESPaclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease
  20. TAXUS V ISRPaclitaxel-Eluting Stents Vs. Brachytherapy For In-Stent Restenosis
  21. TAXiPaclitaxel And Sirolimus Stents In The Real World Of Interventional Cardiology
  22. PASSIONPaclitaxel Eluting Stent Versus Conventional Stent In St-Segment Elevation Myocardial Infarction
  23. PanophobiaPanphobia
  24. PanthophobiaPanphobia
  25. PansexualPansexuality
  26. Papillary tumors of the pineal regionPapillary tumor of the pineal region
  27. Papillary tumour of the pineal regionPapillary tumor of the pineal region
  28. Papillary tumours of the pineal regionPapillary tumor of the pineal region
  29. PTPRPapillary tumor of the pineal region
  30. Cryptogenic StrokeParaoxical embolism
  31. Partial least squaresPartial least squares regression
  32. Paul Hermann MullerPaul Hermann Müller
  33. Paul M. NursePaul Nurse
  34. Paul von Rague SchleyerPaul von Ragué Schleyer
  35. DioscoridesPedanius Dioscorides
  36. PaedophiliaPedophilia
  37. Pedophilic disorderPedophilia
  38. PaiderastiaPedophilia
  39. Paedophilia eroticaPedophilia
  40. PENTUAPentasaccharide In Unstable Angina
  41. PETAPeople for the Ethical Treatment of Animals
  42. PCI-ExTRACT-TIMI 25Percutaneous Coronary Intervention Among Patients Treated With Enoxaparin Versus Unfractionated Heparin Following Fibrinolytic Administration For St-Elevation Mi
  43. PACIFICPercutaneous Transmyocardial Laser Revascularization For Severe Angina: The Pacific Randomized Trial
  44. POZNANPercutaneous Transvenous Transplantation Of Autologous Myoblasts In The Treatment Of Postinfarction Heart Failure
  45. PERTINENTPerindopril, Thrombosis, Inflammation, Endothelial Dysfunction, And Neurohormonal Activation Trial, A Subanalysis Of Europa
  46. PEP-CHFPerindopril For Elderly People With Chronic Heart Failure
  47. PROGRESSPerindopril Protection Against Recurrent Stroke Study
  48. PREAMIPerindopril Remodeling In Elderly With Acute Myocardial Infarction
  49. PERSUADEPerindopril Substudy In Coronary Artery Disease And Diabetes: The Diabetic Substudy Of Europa
  50. POISEPerioperative Ischemic Evaluation
  51. Permian-Triassic extinctionPermian–Triassic extinction event
  52. PPAR StudyPeroxisome Proliferator–Activated Receptor Study
  53. Sexual lubricantPersonal lubricant
  54. Personality testsPersonality test
  55. PerthPerth Community Stroke Study
  56. Peter J. D'AdamoPeter D'Adamo
  57. Peter J.W. DebyePeter Debye
  58. Peter J. W. DebyePeter Debye
  59. Peter Brian MedawarPeter Medawar
  60. PRIMO-CABG IIPexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft II
  61. PRIMO-CABGPexelizumab For The Reduction Of Infarction And Mortality In Coronary Artery Bypass Graft Surgery Study
  62. Warner-LambertPfizer
  63. PhallicPhallus
  64. Pharmaceutical industryPharmaceutical company
  65. Drug companyPharmaceutical company
  66. Pharmaceutical companiesPharmaceutical company
  67. Pharmaceutical manufacturerPharmaceutical company
  68. Drug companiesPharmaceutical company
  69. Muscles of the pharynxPharyngeal muscles
  70. Pharyngeal ostiumPharyngeal opening of auditory tube
  71. Rivaroxaban Demonstrated to be Safe and Efficacious in ATLAS- TIMI 46Phase II results of ATLAS ACS presented
  72. Sid BriskinPhiladelphia Association
  73. Phillip SharpPhillip Allen Sharp
  74. PLASMAPhospholipase Levels And Serological Markers Of Atherosclerosis
  75. PhotonsPhoton
  76. PC-TrialPhysical Counterpressure Manoeuvre Trial
  77. PHS IIPhysicians' Health Study II
  78. Pierre Simon de LaplacePierre-Simon Laplace
  79. RobiquetPierre Jean Robiquet
  80. Emile RouxPierre Paul Émile Roux
  81. PorcinePig
  82. Pilocytic astrocytoma natural historyPilocytic astrocytoma natural history, complications and prognosis
  83. Pineal TumorsPineal parenchymal tumors
  84. PERISCOPEPioglitazone Effect On Regression Of Intravascular Sonographic Coronary Obstruction Prospective Evaluation
  85. EncellePioneer Surgical Technology
  86. PitchPitch (music)
  87. Musical pitchPitch (music)
  88. PACTPlasminogen Activator-Angioplasty Compatibility Trial
  89. PRISMPlatelet-Receptor Inhibition For Ischemic Syndrome Management
  90. PRISM-PLUSPlatelet-Receptor Inhibition For Ischemic Syndrome Management In Patients Limited By Unstable Signs And Symptoms
  91. PURSUITPlatelet Glycoprotein IIb/IIia In Unstable Angina:Receptor Suppression Using Integrilin Therapy
  92. PARAGON BPlatelet IIb/IIia Antagonist For The Reduction Of Acute Coronary Syndrome Events In A Global Organization Network
  93. PIHRATEPolish-Italian-Hungarian Randomized Thrombectomy Trial
  94. PolysexualPolysexuality
  95. PomponPom-pon
  96. PICTUREPost-Intracoronary Treatment Ultrasound Result Evaluation
  97. Post CABGPost Coronary Artery Bypass Graft Trial
  98. Post PCI Medical Management of the Interventional PatientPost PCI medical management of the interventional patient
  99. PEPIPostmenopausal Estrogen/Progestin Interventions
  100. Post-infectious streptococcal glomerulonephritisPoststreptococcal glomerulonephritis
  101. Post strep GNPoststreptococcal glomerulonephritis
  102. Povidone iodine (patient information)Povidone iodine#Patient Counseling Information
  103. PLAC-IIPravastatin, Lipids, And Atherosclerosis In The Carotid Arteries II
  104. PACT (Pravastatin)Pravastatin In Acute Coronary Treatment
  105. Predictors of Major Coronary Complications of Coronary AngiographyPredictors of major coronary complications of coronary angiography
  106. 3rd trimesterPregnance#Third trimester
  107. Hypertension of pregnancyPregnancy induced hypertension
  108. Pregnancy-induced hypertensionPregnancy induced hypertension
  109. PIHPregnancy induced hypertension
  110. Gestational hypertensionPregnancy induced hypertension
  111. RaMIPrehospital Thrombolysis In Rural Emergency Room And Subsequent Transport To A Coronary Care Unit: Ravenna Myocardial Infarction (Rami) Trial
  112. EMIPPrehospital Thrombolytic Therapy In Patients With Suspected Acute Myocardial Infarction
  113. PRESENTPreliminary Safety Evaluation Of Nanoporous Tacrolimus Eluting Stents
  114. Pre-RELAX-AHFPreliminary Study Of Relaxin In Acute Heart Failure
  115. Rattlesnake rootPrenanthes
  116. Preparation of the Patient for Percutaneous Coronary Intervention (PCI)Preparation of the patient for percutaneous coronary intervention (PCI)
  117. RxPPrescriptive authority for psychologists movement
  118. PACEPrevention By Low Dose Aspirin Of Cardiovascular Disease In The Elderly
  119. PRINCESSPrevention Of Ischaemic Events By Early Treatment Of Cerivastatin After Acute Myocardial Infarction
  120. STIMSPrevention Of Myocardial Infarction And Stroke In Patients With Intermittent Claudication
  121. PREVEND ITPrevention Of Renal And Vascular End-Stage Disease Intervention Trial
  122. POSTPrevention Of Syncope Trial
  123. LOCATPrevention Of The Angiographic Progression Of Coronary And Vein-Graft Atherosclerosis By Gemfibrozil After Coronary Bypass Surgery In Men With Low Levels Of Hdl Cholesterol
  124. PRoFESSPrevention Regimen For Effectively Avoiding Second Strokes
  125. PRAGUEPrimary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis
  126. PRAGUE-8Primary Angioplasty In Patients Transferred From General Community Hospitals To Specialized Ptca Units With Or Without Emergency Thrombolysis-8
  127. GRACIA IIPrimary Optimal Percutaneous Coronary Intervention Versus Facilitated Intervention In Stemi Patients
  128. PATAFPrimary Prevention Of Arterial Thromboembolism In Non-Rheumatic Atrial Fibrillation In Primary Care: Randomised Controlled Trial Comparing Two Intensities Of Coumarin With Aspirin
  129. PPPPrimary Prevention Project
  130. PrimatesPrimate
  131. PRIMIPro-Urokinase For Myocardial Infarction
  132. PIONEERProactive, Prospective Pioglitazone Clinical Trial In Macrovascular Events
  133. PQRSTProbucol Quantitative Regression Swedish Trial
  134. POSCHProgram On The Surgical Control Of The Hyperlipidemias
  135. PATCHProgram To Assess Alternative Treatment Strategies To Achieve Cardiac Health
  136. Programmed cell death 1,Programmed cell death 1
  137. PREVENT IVProject Of Ex-Vivo Vein Graft Engineering Via Transfection
  138. PREVENT(Radiation)Proliferation Reduction With Vascular Energy Trial
  139. PAPABEARProphylactic Amiodarone For The Prevention Of Arrhythmias That Begin Early After Revascularization, Valvular Repair Or Replacement
  140. MEDENOXProphylaxis In Medical Patients With Enoxaparin
  141. Propositional logicPropositional calculus
  142. LAVAProspective, Randomized, Multicenter Comparison Of Laser-Facilitated Balloon Angioplasty Versus Stand-Alone Balloon Angioplasty In Patients With Obstructive Coronary Artery Disease
  143. PREVENT (Dalteparin)Prospective Evaluation Of Dalteparin Efficacy For Prevention Of Vte In Immobilized Patients Trial
  144. PEECHProspective Evaluation Of Enhanced External Counterpulsation In Congestive Heart Failure
  145. PERMProspective Evaluation Of Reperfusion Markers
  146. PROVIDENCE 1Prospective Evaluation Of Rifalazil Effect On Vascular Symptoms Of Intermittent Claudication And Other Endpoints In Chlamydia Seropositive Patients
  147. PIOPEDProspective Investigation Of Pulmonary Embolism Diagnosis Study
  148. PROactiveProspective Pioglitazone Clinical Trial In Macrovascular Events
  149. PRAISE-1Prospective Randomized Amlodipine Survival Evaluation-1
  150. PRAISE-2Prospective Randomized Amlodipine Survival Evaluation-2
  151. PRAISEProspective Randomized Amlopidine Survival Evaluation
  152. PROFILEProspective Randomized Flosequinan Longevity Evaluation
  153. REALITYProspective Randomized Multi-Center Head-To-Head Comparison Of The Sirolimus-Eluting Stent (Cypher) And The Paclitaxel-Eluting Stent (Taxus
  154. PROTECT-CADProspective Randomized Trial Of Direct Endomyocardial Implantation Of Bone Marrow Cells For Therapeutic Angiogenesis In Coronary Artery Diseases
  155. PRESERVEProspective Randomized Trial Of Enalapril To Reverse Ventricular Enlargement
  156. PRISON IIProspective Randomized Trial Of Sirolimus-Eluting And Bare Metal Stents In Patients With Chronic Total Occlusions
  157. PTGER3Prostaglandin E receptor 3
  158. PREMIARProtection From Distal Embolization In High-Risk Patients With Acute St-Segment Elevation Myocardial Infarction
  159. ProteanProteus (bacterium)
  160. PIRAProvisional Irish Republican Army
  161. PREPARE — Presented at TCT 2008Proximal Embolic Protection In Acute Mi And Resolution Of St-Elevation
  162. PROXIMALProximal Protection During Saphenous Vein Graft Intervention
  163. PEPPulmonary Embolism Prevention Trial
  164. PABA CHFPulmonary Vein Antrum Isolation Vs. Av Node Ablation With Biventricular Pacing For Treatment Of Atrial Fibrillation In Patients With Congestive Heart Failure
  165. ACC/AHA guidelines surgical embolectomyPulmonary embolism ACC/AHA guidelines surgical embolectomy
  166. Catheter-Based InterventionsPulmonary embolism catheter based interventions
  167. ACC/AHA guidelines inferior vena cava filterPulmonary embolism guidelines inferior vena cava filter
  168. Pulmonary embolism ACC/AHA guidelines inferior vena cava filterPulmonary embolism guidelines inferior vena cava filter
  169. Pyridoxine hydrochloridePyridoxine hydrochloride (injection)
  170. PASE(QOL)Quality Of Life And Clinical Outcomes In Elderly Patients Treated With Ventricular Pacing As Compared With Dual-Chamber Pacing
  171. QUASARQuinapril Anti-Ischemia And Symptoms Of Angina Reduction
  172. QUIETQuinapril Ischemic Event Trial
  173. R programming languageR (programming language)
  174. RacialRace (classification of human beings)
  175. Race in biomedicineRace and health
  176. Racoviţa River (Olt)Racoviţa River (Sibiu)
  177. RAPSRadial Artery Patency Study
  178. RSVPRadial Artery Versus Saphenous Vein Patency
  179. Radio-frequencyRadio frequency
  180. RadiofrequencyRadio frequency
  181. RadiopaqueRadiopacity
  182. Radio-opaqueRadiopacity
  183. RUTHRaloxifene Use For The Heart
  184. RanbaxyRanbaxy Laboratories
  185. Random-effects modelsRandom effects model
  186. SESAIRRandomised Comparison Of Subcutaneous Heparin, Intravenous Heparin, And Aspirin In Unstable Angina
  187. HANERandomized, Double-Blind Multicenter Comparison Of Hydrochlorothiazide, Atenolol, Nitrendipine, And Enalapril In Antihypertensive Treatment
  188. COMMIT/CCS-2 – ClopidogrelRandomized, Placebo-Controlled Trial Of Adding Clopidogrel To Aspirin In 46,000 Acute Myocardial Infarction Patients
  189. COMMIT/CCS-2 – MetoprololRandomized, Placebo-Controlled Trial Of Early Metoprolol In 46,000 Acute Myocardial Infarction Patients
  190. RAAMIRandomized Angiographic Trial Of Recombinant Tissue-Type Plasminogen Activator (Alteplase) In Myocardial Infarction
  191. RABBIT IIRandomized Angioplasty Beta Blocker Intracoronary Trial II
  192. RACSRandomized Argentine Clopidogrel Stent Trial
  193. Comparison of GR-II Stent and Palmaz-Schatz Stent for Elective Treatment of Coronary StenosisRandomized Clinical Trial Investigators. Randomized Comparison Of Gr-II Stent And Palmaz-Schatz Stent For Elective Treatment Of Coronary Stenosis
  194. HART IIRandomized Comparison Of Enoxaparin, A Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive To Recombinant Tissue Plasminogen Activator Thrombolysis And Aspirin: Second Trial Of Heparin And Aspirin Reperfusion Therapy
  195. LONG DES IIRandomized Comparison Of The Efficacy Of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent In The Treatment Of Long Native Coronary Lesions
  196. ENDEAVOR IIRandomized Comparison Of The Endeavor Abt-578 Drug Eluting Stent With A Bare Metal Stent For Coronary Revascularization
  197. ENDEAVOR IVRandomized Comparison Of Zotarolimus-Eluting And Paclitaxel-Eluting Stents In Patients With Coronary Artery Disease-4
  198. ENDEAVOR IIIRandomized Comparison Of Zotarolimus-Eluting And Sirolimus-Eluting Stents In Patients With Coronary Artery Disease-3
  199. RELAx-AMIRandomized Early Versus Late Abciximab In Acute Myocardial Infarction Treated With Primary Coronary Intervention
  200. RESTORERandomized Efficacy Study Of Tirofiban For Outcome And Restenosis
  201. RENEWAL - RENAISSANCERandomized Etanercept North American Strategy To Study Antagonism Of Cytokines
  202. MATTISRandomized Evaluation Of Anticoagulation Versus Antiplatelet Therapy After Coronary Stent Implantation In High-Risk Patients: The Multicenter Aspirin And Ticlopidine Trial After Intracoronary Stenting
  203. REMATCHRandomized Evaluation Of Mechanical Assistance For The Treatment Of Congestive Heart Failure
  204. REPLACE 2Randomized Evaluation Of Pci Linking Angiomax To Reduced Clinical Events
  205. RECOVERSRandomized Evaluation Of Polytetrafluoroethylene-Covered Stent In Saphenous Vein Grafts
  206. RESCUERandomized Evaluation Of Salvage Angioplasty With Combined Utilization Of Endpoints
  207. RESOLVDRandomized Evaluation Of Strategies For Left Ventricular Dysfunction Pilot
  208. REMEDIARandomized Evaluation Of The Effect Of Mechanical Reduction Of Distal Embolization By Thrombus-Aspiration In Primary And Rescue Angioplasty
  209. RITARandomized Intervention Treatment Of Angina Trial
  210. RITZ 2Randomized Intravenous Tezosentan For The Treatment Of Acute Heart Failure
  211. RITZ-4Randomized Intravenous Tezosentan Study
  212. FANTASTICRandomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
  213. ROADMAPRandomized Olmesartan And Diabetes Microalbuminuria Prevention Trial
  214. PROVEDRandomized Study Assessing The Effect Of Digoxin Withdrawal In Patients With Mild To Moderate Chronic Congestive Heart Failure: Results Of The Proved
  215. GRACIA IRandomized Trial Comparing Stenting Within 24 Hours Of Thrombolysis Versus Ischemia-Guided Approach To Thrombolysed Acute Myocardial Infarction With St Elevation
  216. RITA-3Randomized Trial Of A Conservative Treatment Strategy Versus An Interventional Treatment Strategy In Patients With Unstable Angina
  217. SYMPHONY IIRandomized Trial Of Aspirin, Sibrafiban, Or Both For Secondary Prevention After Acute Coronary Syndromes
  218. GIPSRandomized Trial Of Glucose-Insulin-Potassium Infusion On 30 Day Mortality In Patients With Acute Myocardial Infarction Treated With Primary Angioplasty
  219. GESICARandomized Trial Of Low-Dose Amiodarone In Severe Congestive Heart Failure
  220. DECOPIRandomized Trial Of Occluded Artery Angioplasty After Acute Myocardial Infarction
  221. OMEGARandomized Trial Of Omega-3 Fatty Acids On Top Of Modern Therapy After Acute Myocardial Infarction
  222. ROSTERRandomized Trial Of Rotational Atherectomy Versus Balloon Angioplasty For Diffuse In-Stent Restenosis
  223. DIALRandomized Trial Of Telephone Intervention In Chronic Heart Failure
  224. ISAR-TESTRandomized Trial Of The Yukon Nonpolymer-Based Rapamycin-Coated Stent And The Polymer-Based Paclitaxel-Eluting Stent In Patients With Coronary Artery Disease
  225. PROTECT - TIMI 30Randomized Trial To Evaluate The Relative Protection Against Post-Pci Microvascular Dysfunction And Post-Pca Ischemia Among Anti-Platelet And Anti-Thrombotic Agents
  226. Rao-Blackwell theoremRao–Blackwell theorem
  227. RESEARCHRapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital Registry
  228. REDHOTRapid Emergency Department Heart Failure Outpatient Trial
  229. RACERate Control Versus Electrical Cardioversion For Persistent Atrial Fibrillation
  230. I-PRESERVERbesartan In Heart Failure With Preserved Ejection Fraction Study
  231. Lancefield antigenRebecca Lancefield
  232. ROBUSTRecanalization Of Chronically Occluded Aorto-Coronary Saphenous Vein Bypass Grafts With Long-Term, Low Dose Direct Infusion Of Urokinase Trial
  233. RAPID-1Recombinant Plasminogen Activator Angiographic Phase II International Dose-Finding Study
  234. Recursive least squaresRecursive least squares filter
  235. REACH RegistryReduction Of Atherothrombosis For Continued Health Registry
  236. RAVERegional Angiogenesis With Vascular Endothelial Growth Factor In Peripheral Arterial Disease
  237. RIVIERA RegistryRegistry On Intra-Venous Anticoagulation In The Elective And Primary Real World Of Angioplasty
  238. RECORD1Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 1
  239. RECORD2Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 2
  240. RECORD3Regulation Of Coagulation In Orthopedic Surgery To Prevent Deep Venous Thrombosis And Pulmonary Embolism 3
  241. REACHReinforcing Education About Cholesterol
  242. REPAIR-AMIReinfusion Of Enriched Progenitor Cells And Infarct Remodeling In Acute Myocardial Infarction
  243. RELOADReload With Clopidogrel Before Coronary Angioplasty In Subjects Treated Long Term With Dual Antiplatelet Therapy
  244. REMEDIALRenal Insufficiency Following Contrast Media Administration Trial
  245. RECOVERRenal Toxicity Evaluation And Comparison Between Visipaque And Hexabrix In Patients With Renal Insufficiency Undergoing Coronary Angiography
  246. Reversible renal failureRenal insufficiency overview#Reversible Renal Failure
  247. Reversible Renal FailureRenal insufficiency overview#Reversible Renal Failure
  248. Rene Theophile Hyacinthe LaennecRené Laennec
  249. RAPPORTReopro And Primary Ptca Organization And Randomized Trial
  250. R3Reopro Readministration Registry
  251. RENEWAL - RECOVERResearch Into Etanercept Cytokine Antagonism In Ventricular Dysfunction
  252. RISCResearch On Instability In Coronary Artery Disease
  253. RESTRestenosis Stent Trial
  254. PRESTOResults Of Prevention Of Restenosis With Tranilast And Its Outcomes (Presto) Trial.
  255. RHYTHM II ICDResynchronization For The Hemodynamic Treatment For Heart Failure Management II Implantable Cardioverter Defibrillator
  256. REVERSEResynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction
  257. Resynchronization Therapy: RethinQ Trial UpdatesResynchronization Therapy Fails to Improve Outcomes in CHF Patients in the RethinQ Trial
  258. RethinQResynchronization Therapy In Patients With Narrow Qrs
  259. RAPID-2Reteplase Vs Alteplase Patency Investigation During Myocardial Infarction
  260. REVERTReversal Of Ventricular Remodeling With Toprol-Xl
  261. User:MedasdunReverse phone lookup
  262. REVERSALReversing Atherosclerosis With Aggressive Lipid Lowering
  263. RhinoscopyRhinoscope
  264. PIAFRhythm Or Rate Control In Atrial Fibrillation-Pharmacological Intervention In Atrial Fibrillation (Piaf): A Randomised Trial
  265. Rickettsial DiseaseRickettsia
  266. Rickettsial diseaseRickettsia
  267. RickettsialRickettsia
  268. RickettsiaeRickettsia
  269. RickettsiaceaeRickettsia
  270. RAPTRidogrel Versus Aspirin Patency Trial
  271. Measuring the Effects of Rifalazil on PAD: Update on the Progress of the PROVIDENCE I TrialRifalazil Does not Improve Outcomes in PAD Patients:Providence 1
  272. ARPEGGIORimonabant Improves Glycemic Control In Insulin-Treated Type 2 Diabetes
  273. RIO-LipidsRimonabant In Obesity
  274. RIO-NARimonabant On Weight Reduction And Weight Maintenance: Rio-North America
  275. Rinderpest virusRinderpest
  276. RisksRisk
  277. River Out of EdenRiver out of Eden
  278. Robert MillikanRobert Andrews Millikan
  279. J. Robin WarrenRobin Warren
  280. Rodney PorterRodney Robert Porter
  281. Rodney R. PorterRodney Robert Porter
  282. Roger David KornbergRoger D. Kornberg
  283. Roger W. SperryRoger Wolcott Sperry
  284. ROMASRomanian Multicenter Study - Accelerated Streptokinase In Acute Myocardial Infarction
  285. Rosalyn YalowRosalyn Sussman Yalow
  286. Rosewood oilRosewood (timber)#In essential oil
  287. RECORDRosiglitazone Evaluated For Cardiovascular Outcomes — An Interim Analysis
  288. ROXISRoxithromycin In Non-Q Wave Coronary Syndromes
  289. Royal College Of Paediatrics and Child HealthRoyal College of Paediatrics and Child Health
  290. Fellow of the Royal College of PhysiciansRoyal College of Physicians
  291. Royal College of Surgeons of LondonRoyal College of Surgeons of England
  292. Royal JellyRoyal jelly
  293. Rudolf VirchowRudolph Carl Virchow
  294. Rudolph VirchowRudolph Carl Virchow
  295. Rune ElmquistRune Elmqvist
  296. MilliremRöntgen equivalent man
  297. RemRöntgen equivalent man
  298. ST Elevation Myocardial Infarction Arrhythmia MonitoringST elevation myocardial infarction arrhythmia monitoring
  299. S programming languageS (programming language)
  300. Sadism and MasochismSadomasochism
  301. SAFESafety After Fifty Evaluation
  302. SEISMICSafety And Effects Of Implanted (Autologous) Skeletal Myoblasts (Myocell) Using An Injection Catheter
  303. RUSSLANSafety And Efficacy Of A Novel Calcium Sensitizer, Levosimendan, In Patients With Left Ventricular Failure Due To An Acute Myocardial Infarction
  304. SIRIUS-2Safety And Efficacy Of An Intravenous Placebo-Controlled Randomized Infusion Of Ularitide
  305. APPRAISE-1Safety Of The Factor Xa Inhibitor, Apixaban, In Combination With Antiplatelet Therapy After Acute Coronary Syndromes: A Dose-Guiding Trial
  306. St. Louis UniversitySaint Louis University
  307. Sublingual gland cancerSalivray gland tumor
  308. Samuel Guthrie (U.S. physician)Samuel Guthrie (United States physician)
  309. Samuel Siegfried Carl von BaschSamuel Siegfried Karl von Basch
  310. Santorio SantorioSanctorius
  311. Sanofi-aventisSanofi-Aventis
  312. Sanofi AventisSanofi-Aventis
  313. SAVEDSaphenous Vein De Novo
  314. PCI in Saphenous Vein GraftsSaphenous Vein Graft
  315. SaunasSauna
  316. Schering AGSchering
  317. Odd beliefSchizotypal personality behavior
  318. Scopes Monkey TrialScopes Trial
  319. SALTIREScottish Aortic Stenosis And Lipid Lowering Trial
  320. SCRIPPSScripps Coronary Radiation To Inhibit Proliferation Post Stenting
  321. SCRIPPS IIScripps Coronary Radiation To Inhibit Proliferation Post Stenting II
  322. SCRIPPS IIIScripps Coronary Radiation To Inhibit Proliferation Post Stenting III
  323. SCRIPPS IVScripps Coronary Radiation To Inhibit Proliferation Post Stenting Iv
  324. SAVE PACeSearch Av Extension And Managed Ventricular Pacing For Promoting Atrioventricular Conduction
  325. AFASAK-2Second Copenhagen Atrial Fibrillation, Aspirin, And Anticoagulation Study
  326. LIMIT-2Second Leicester Magnesium Intervention Trial
  327. MASS-IISecond Medicine, Angioplasty, Or Surgery Study
  328. PRIME-2Second Prospective Randomized Study Of Ibopamine On Mortality And Efficacy In Heart Failure
  329. WITTI WomenSecondary Prevention Beyond Walls Intervention Trial In Women
  330. SPACESecondary Prevention With Antioxidants Of Cardiovascular Disease In End-Stage Renal Disease (Space): Randomized Placebo-Controlled Trial
  331. Secondary ionisationSecondary ionization
  332. Selman Abraham WaksmanSelman Waksman
  333. SENIOR PAMISenior Primary Angioplasty In Myocardial Infarction Study
  334. Serous tumourSerous tumor
  335. SADHARTSertraline Treatment Of Major Depression In Patients With Acute Mi Or Unstable Angina
  336. ACCTSex And Age Related Antihypertensive Effects Of Amlodipine
  337. Adult entertainmentSex industry
  338. Sex change operationSex reassignment therapy
  339. Sexual reassignmentSex reassignment therapy
  340. Sexual interestSexual attraction
  341. Sexual fetishSexual fetishism
  342. IntercourseSexual intercourse
  343. CoitusSexual intercourse
  344. Sex (activity)Sexual intercourse
  345. Vaginal intercourseSexual intercourse
  346. Vaginal sexSexual intercourse
  347. Sexual contactSexual intercourse
  348. Sexual preferenceSexual orientation
  349. ShamanShamanism
  350. STONEShanghai Trial Of Nifedipine In The Elderly
  351. Goatpox virusSheeppox and goatpox
  352. Sheeppox virusSheeppox and goatpox
  353. Shelf-lifeShelf life
  354. ShenShen (Chinese "spirit; god")
  355. SHIELDShock Inhibition Evaluation With Azimilide
  356. SHOCKShould We Emergently Revascularize Occluded Coronaries For Cardiogenic Shock?
  357. SWIFTShould We Intervene Following Thrombolysis?
  358. SYMPHONY ISibrafiban Versus Aspirin To Yield Maximum Protection From Ischemic Heart Events Post-Acute Coronary Syndromes
  359. SievertsSievert
  360. SiliconesSilicone
  361. AZQSilk Way Airlines
  362. Silver carbideSilver acetylide
  363. PROCAMSimple Scoring Scheme For Calculating The Risk Of Acute Coronary Events Based On The 10-Year Follow-Up Of The Prospective Cardiovascular Münster (Procam) Study
  364. SEASSimvastatin And Ezetimibe In Aortic Stenosis
  365. ENHANCESimvastatin With Or Without Ezetimibe In Familial Hypercholesterolemia
  366. WikiDoc state of the art review on ZocorSimvastatin detailed information
  367. SinusoidSine wave
  368. STRATEGYSingle High-Dose Bolus Tirofiban And Sirolimus-Eluting Stent Vs. Abciximab And Bare-Metal Stent In Myocardial Infarction
  369. Sphenoid sinusitisSinusitis classification
  370. Thomas Barlow (medicine)Sir Thomas Barlow, 1st Baronet
  371. SES-SMARTSirolimus-Eluting Stent And A Standard Stent In The Prevention Of Restenosis In Small Coronary Arteries
  372. SIRTAXSirolimus-Eluting Stent Compared With Paclitaxel-Eluting Stent For Coronary Revascularization
  373. SIRIUSSirolimus-Eluting Stent In Coronary Lesions
  374. SESAMISirolimus-Eluting Stent Versus Bare-Metal Stent In Acute Myocardial Infarction
  375. SISRSirolimus-Eluting Stent Vs. Brachytherapy In Patients With Bare Metal In-Stent Restenosis
  376. Slim-FastSlim Fast
  377. Small cell carcinoma laboratory testsSmall cell carcinoma laboratory findings
  378. Small cell carcinoma natural history, complications, and prognosisSmall cell carcinoma natural history, complications and prognosis
  379. STRATUS-USSmoking Cessation In Smokers Motivated To Quit
  380. Cobra ToxinSnake venom
  381. Social impact of H5N1Social effects of H5N1
  382. Autistic communitySociological and cultural aspects of autism
  383. SociologicalSociology
  384. TONESodium Reduction And Weight Loss In The Treatment Of Hypertension In Older Persons: A Randomized Controlled Trial Of Nonpharmacologic Interventions In The Elderly
  385. Solvay PharmaceuticalSolvay (company)
  386. SAFE-TSotalol Amiodarone Atrial Fibrillation Efficacy Trial
  387. SIAM IIISouthwest German Interventional Study In Acute Myocardial Infarction
  388. SSSDSpanish Study On Sudden Death
  389. Spanish FluSpanish flu
  390. SPAN CHFSpecialized Primary And Networked Care In Heart Failure
  391. Spectral linesSpectral line
  392. Absorption lineSpectral line
  393. Emission lineSpectral line
  394. Squamous cell carcinoma causes of squamous cell carcinomaSquamous cell carcinoma causes
  395. Squamous cell carcinoma future and investigational treatment strategiesSquamous cell carcinoma future or investigational therapies
  396. Squamous cell carcinoma historical aspectsSquamous cell carcinoma historical perspective
  397. Squamous cell carcinoma laboratory testsSquamous cell carcinoma laboratory findings
  398. Squamous cell carcinoma medical treatmentSquamous cell carcinoma medical therapy
  399. Squamous cell carcinoma natural historySquamous cell carcinoma natural history, complications and prognosis
  400. Squamous cell carcinoma surgical treatmentSquamous cell carcinoma surgery
  401. STARTSr90 Treatment Of Angiographic Restenosis
  402. St. Andrew’s Ambulance AssociationSt. Andrew's Ambulance Association
  403. St Jude Children's Research HospitalSt. Jude Children's Research Hospital (Memphis, Tennessee)
  404. STARS-AtherosclerosisSt. Thomas Atherosclerosis Regression Study
  405. St. George's Hospital Medical SchoolSt George's, University of London
  406. St John's Institute of DermatologySt Thomas' Hospital
  407. Stanford-Binet Intelligence ScaleStanford-Binet IQ test
  408. Stanford-BinetStanford-Binet IQ test
  409. Stanley CohenStanley Cohen (biochemist)
  410. Stanley Cohen (doctor)Stanley Cohen (biochemist)
  411. FPAStaring array
  412. STEMMIStem Cells In Myocardial Infarction
  413. STARS-AntithromboticStent Antithrombotic Regimen Study
  414. SARECCOStent Or Angioplasty After Recanalization Of Chronic Coronary Occlusions Trial
  415. STENT PAMIStent Primary Angioplasty In Mi
  416. STRESS IStent Restenosis Study I
  417. STOP-AMI 1Stent Versus Thrombolysis For Occluded Coronary Arteries In Patients With Acute Myocardial Infarction 1
  418. SAPPHIREStenting And Angioplasty With Protection In Patients At High Risk For Endarterectomy
  419. SICCOStenting In Chronic Coronary Occlusion
  420. SCANDSTENTStenting Of Coronary Arteries In Non Stress/Benestent Disease Trial
  421. SMTStockholm Metoprolol Trial
  422. SANDSStop Atherosclerosis In Native Diabetics Study
  423. User:Nancy.michelle748Stop Smoking cigarettes with Electronic electronic Cigarette
  424. STAFStrategies Of Treatment Of Atrial Fibrillation
  425. SPARCLStroke Prevention By Aggressive Reduction In Cholesterol Levels
  426. SPAFStroke Prevention In Atrial Fibrillation Study
  427. SPINAFStroke Prevention In Nonrheumatic Atrial Fibrillation
  428. SPORTIF VStroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
  429. SPORTIF IIIStroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
  430. SPORTIF IIStroke Prevention Using The Oral Direct Thrombin Inhibitor Ximelagatran In Patients With Nonvalvular Atrial Fibrillation
  431. StrontiaStrontium oxide
  432. SAGEStudy Assessing Goals In The Elderly
  433. SALT 1 and 2Study Of Ascending Levels Of Tolvaptan In Hyponatremia
  434. SCRIPStudy Of Cardiovascular Risk Intervention By Pharmacists
  435. SENIORSStudy Of Effects Of Nebivolol Intervention On Outcomes And Rehospitalisation In Seniors With Heart Failure
  436. SIMPADICOStudy Of Immune Modulation Therapy In Patients With Symptomatic Peripheral Arterial Disease
  437. SPICEStudy Of Patients Intolerant Of Converting Enzyme Inhibitors
  438. SEARCHStudy Of The Effectiveness Of Additional Reductions In Cholesterol And Homocysteine
  439. STEPStudy Of The Therapeutic Effects Of Intercessory Prayer
  440. SOFAStudy On Omega-3 Fatty Acids And Ventricular Arrhythmia
  441. SCOREStudy To Compare Restenosis Rate Between Quest And Quadds-Qp2
  442. STRATASStudy To Determine Rotablator And Transluminal Angioplasty Strategy
  443. SECUREStudy To Evaluate Carotid Ultrasound Changes In Patients Treated With Ramipril And Vitamin E
  444. STOP-NIDDMStudy To Prevent Noninsulin Dependent Diabetes Mellitus Trial
  445. SubatomicSubatomic particle
  446. Subatomic particlesSubatomic particle
  447. MatisseSubcutaneous Fondaparinux Versus Intravenous Unfractionated Heparin In The Initial Treatment Of Pulmonary Embolism
  448. SubmissivenessSubmissive
  449. SMASH-VTSubstrate Mapping And Ablation In Sinus Rhythm To Halt Ventricular Tachycardia
  450. SCD-HeFTSudden Cardiac Death In Heart Failure Trial
  451. SuperfruitsSuperfruit
  452. CERCLASuperfund
  453. SYNERGYSuperior Yield Of The New Strategy Of Enoxaparin, Revascularization, And Glycoprotein IIb/IIia Inhibitors
  454. Suporn techniqueSuporn Watanyusakul
  455. STICHSurgical Treatments For Ischemic Heart Failure Hypothesis 2
  456. SPICE – Presented at ACC 2007Survival And Prognosis: Investigation Of Crataegus Extract Ws 1442 In Chf
  457. SAVESurvival And Ventricular Enlargement Trial
  458. SURVIVESurvival Of Patients With Acute Heart Failure In Need Of Intravenous Inotropic Support
  459. SWORDSurvival With Oral D-Sotalol Trial
  460. ArrheniusSvante Arrhenius
  461. SALTSwedish Aspirin Low-Dose Trial
  462. SWEDESSwedish Early Decision Trial
  463. SWISHSwedish Isradipine Study In Hypertension
  464. STOP-HTNSwedish Trial In Old Patients With Hypertension
  465. SWISSI IISwiss Interventional Study On Silent Ischemia Type II
  466. SWITCHSwitching From Lovenox To Angiomax In Patients With Acute Coronary Syndromes Without St Elevation Undergoing Pci
  467. SEEDSSyncope Evaluation In The Emergency Department Study
  468. SyntheticSynthetic fiber
  469. SPRINTSystolic Blood Pressure Intervention Trial
  470. Systolic blood pressure intervention trialSystolic Blood Pressure Intervention Trial
  471. Systolic blood pressure interventionSystolic Blood Pressure Intervention Trial
  472. Systolic Blood Pressure InterventionSystolic Blood Pressure Intervention Trial
  473. A Randomized Trial of Intensive versus Standard Blood-Pressure ControlSystolic Blood Pressure Intervention Trial
  474. A Randomized Trial of Intensive versus Standard Blood Pressure ControlSystolic Blood Pressure Intervention Trial
  475. A randomized trial of intensive versus standard blood pressure controlSystolic Blood Pressure Intervention Trial
  476. Randomized trial of intensive versus standard blood pressure controlSystolic Blood Pressure Intervention Trial
  477. Randomized trial of intensive versus standard blood-pressure controlSystolic Blood Pressure Intervention Trial
  478. A randomized trial of intensive versus standard blood-pressure controlSystolic Blood Pressure Intervention Trial
  479. SPRINT trialSystolic Blood Pressure Intervention Trial
  480. SPRINT TrialSystolic Blood Pressure Intervention Trial
  481. Syst-ChinaSystolic Hypertension In China Trial
  482. SHEPSystolic Hypertension In Elderly Program
  483. ALPHAT-Wave Alternans In Patients With Heart Failure
  484. Pediatric T-cell leukemiaT-cell acute lymphoblastic leukemia
  485. Precursor T acute lymphoblastic leukemia/lymphomaT-cell acute lymphoblastic leukemia
  486. Pre-T ALLT-cell acute lymphoblastic leukemia
  487. Mature T ALLT-cell acute lymphoblastic leukemia
  488. Lymphomatous T-cell leukemia/lymphomaT-cell acute lymphoblastic leukemia
  489. Cortical T ALLT-cell acute lymphoblastic leukemia
  490. Pro-T ALLT-cell acute lymphoblastic leukemia
  491. T-acute lymphoblastic lymphomaT-cell acute lymphoblastic leukemia
  492. T-ALLT-cell acute lymphoblastic leukemia
  493. T-LBLT-cell acute lymphoblastic leukemia
  494. Takeda PharmaceuticalsTakeda Pharmaceutical Company
  495. Takeda Pharmaceutical Co.Takeda Pharmaceutical Company
  496. Takeda PharmaceuticalTakeda Pharmaceutical Company
  497. THUNDERTaxan With Short Time For Contact For Reduction Of Restenosis In Distal Arteries
  498. TEN-HMSTelemonitoring For Heart Failure: Patient Characteristics And First Results
  499. TRANSCENDTelmisartan Randomised Assessment Study In Ace Intolerant Subjects With Cardiovascular Disease
  500. TergiteTergum

View ( | ) (20 | 50 | 100 | 250 | 500)